ERICA COLEMAN: Open Payments
NPI 1891279923 · WARRENTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 69 payments from 12 companies in 2025. Trend: 2023 $953 · 2024 $1,416 · 2025 $1,219
Food & beverage: $1,219
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $219 |
| PFIZER INC. | 10 | $201 |
| Amgen Inc. | 11 | $192 |
| ABBVIE INC. | 14 | $184 |
| Astellas Pharma US Inc | 5 | $114 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| Lilly USA, LLC | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Dexcom, Inc. | 1 | $30 |
Products named: Ozempic, NURTEC ODT, Veozah, OTEZLA, VRAYLAR, PREVNAR 20, Rybelsus, QULIPTA.
Industry payments across VA — which companies pay providers there.
